Mochida Pharmaceutical Co., Ltd. (4534.T)

JPY 2980.0

(2.65%)

Market Cap (In JPY)

102.42 Billion

Revenue (In JPY)

102.88 Billion

Net Income (In JPY)

4.54 Billion

Avg. Volume

23.99 Thousand

Currency
JPY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2863.0-3625.0
PE
18.47
EPS
161.3
Beta Value
0.001
ISIN
JP3922800002
CUSIP
-
CIK
-
Shares
34371055.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Naoyuki Mochida
Employee Count
-
Website
https://www.mochida.co.jp
Ipo Date
2001-01-01
Details
Mochida Pharmaceutical Co., Ltd. produces and sells pharmaceuticals, skincare products, and diagnostics solutions in Japan. The company provides cardiovascular, analgesic, gastrointestinal, neurological, anti-infective, antidiabetics, and anticancer products, as well as hormone and biological preparations, and biosimilars; diagnostic reagents, such as reagents for fertility/infertility and other reagents; and face and body care, hair care, and skincare products, as well as dermatology, psychiatry, obstetrics, and gynecology products. It also developing drugs for the treatment of intractable diseases. The company has collaboration agreements with Amarin Corporation plc for the development and commercialization of ethyl icosapentate products; and Gene Techno Science Co., Ltd. to develop new regenerative medicine for the treatment of digestive rare and intractable diseases, such as congenital isolated hypoganglionosis. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.